IDH2 and neoplasm: Patients with unknown IDH mutational status in their tumours had significantly shorter median OS 9.5 months compared to those with IDH wild type tumours, HR1.36, 95% CI [1.06–1.76], p = 0.016, Fig 2C and Table 1.